https://www.selleckchem.com/products/tak-715.html
The purpose of this study was to evaluate the time to medication administration, clinical effect, and safety of a recent Pharmacy and Therapeutics Committee-approved change in the administration of levetiracetam from intravenous piggyback (IVP over 15min to undiluted intravenous push (IVP) over 2-5min at a large academic medical center. The primary outcome was the time from order verification to the administration of IVP levetiracetam versus IVPB levetiracetam. The secondary outcome was any benzodiazepine administered in the time betw
Like
Comment
Share
